Emerging Leaders Committee | APAGE

The ELC of #APAGE (#yAPAGE) aims to support, mentor, connect and nurture future Asia-Pacific leaders in #gastroenterology #hepatology & #endoscopy

[Emerging Leaders Committee | APAGE @ELC_APAGE]

'To allow a whole new cadre of young leaders to be identified more efficiently, so that our twin specialties of gastroenterology and hepatology remain in good hands, and that our contributions to health grow' 🌱🌏 - Prof. Farrell & Neomans #ELC #APAGE

🔗 https://t.co/ocLbgwjwCn

[Journal of Gastroenterology and Hepatology @JGHofficial]

Are we prescribing PPIs longer than necessary? 🤔

A new Southeast Asian expert consensus highlights inappropriate long-term PPI use and offers practical guidance on rationalization, START/STOPP criteria, shared decision-making, and deprescribing 🌏💊

🔗 https://t.co/VOBGRTDEfy

[Journal of Gastroenterology and Hepatology @JGHofficial]

Check out the June issue of the Journal of #Gastroenterology and #Hepatology 📗 #TealJournal

✳️ Updated Epidemiology of GI Cancers in Asia-Pacific
✳️ Rationalizing PPI Use: Southeast Asia Consensus
✳️ Intrahepatic Cholangiocarcinoma Review

And more 🔗 https://t.co/R37h3ninRG

[Rashid Lui 雷諾信 @RashidLui]

Our latest study showed that the mucosal #microbiome of right-sided colorectal cancer #CRC was distinctly different from that of left-sided CRC patients.

@CUHKMedicine

https://t.co/lR2Hfntg8h

[APASL News @APASLnews]

APASL STC 2026 Kumamoto (Sep. 18-19, 2026) will welcome an outstanding lineup of distinguished guests.
We also hope you will take the opportunity to experience the unique charm of Kumamoto.

https://t.co/accYVAAOEV

[Emerging Leaders Committee | APAGE @ELC_APAGE]

Join the Asia Pacific GI Nexus Facebook page and stay updated on the latest GI events across Asia Pacific and beyond 🌏🛜

Hosted by the APAGE-ELC. A GI community built to connect, support, share, and grow. Spread the word! 🗣️ https://t.co/uxInJwzWnp

[Emerging Leaders Committee | APAGE @ELC_APAGE]

Welcome the new APAGE Emerging Leaders Committee cohort 🌏

Founded in 2022, APAGE-ELC is a regional runway to global leadership in gastroenterology and hepatology—driven by education, global platforms, and collaboration.

Exciting initiatives ahead. Stay tuned 🚀

[Emerging Leaders Committee | APAGE @ELC_APAGE]

📢 SAVE THE DATE!
🇲🇾 Kuala Lumpur, Malaysia
📅 9–10 October 2026

Join the 2nd Asia Pacific Neurogastromotility Foundation Course 2026 for two days of expert lectures, hands-on learning, and interactive discussions on GI motility and DGBI 🌏

#APNFC2026 #GIMotility #DGBI #APAGE

[APDW 2026 Manila @apdw2026manila]

⏳ Only 2 weeks left before the #APDW2026Manila Abstract Submission deadline!​
​
Submit your research, connect with global experts, and join the digestive health community in Manila 🇵🇭✨​

🏆 Awards & Grants available​
📅 Deadline: 15 June 2026​
​
#YouGutToBeHere

[World Gastroenterology Organisation (WGO) @WorldGastroOrg]

Happy World Digestive Health Day!

Celebrated each year on 29 May, WDHD is a day to raise awareness on the importance of digestive health.

Help break the #chronicdiarrhea stigma and spread the #DontFlushTheSigns message by tagging WGO in your #WDHD2026 posts,

[Journal of Gastroenterology and Hepatology @JGHofficial]

How effective is FIT-based colorectal cancer screening? 🇯🇵 🇰🇷 🇹🇼 provide compelling evidence: lower CRC mortality and strong cost-effectiveness.

Check out this excellent article from our current issue. 👇 #TealJournal

[APDW 2026 Manila @apdw2026manila]

📅 Mark your calendars for APDW 2026 Manila 🇵🇭​

Join global experts for 5 days of GI education, hands-on workshops & live endoscopy demos.​
​
📍 PICC, Manila​
🗓️ 24–28 Nov 2026​
​
🌐 https://t.co/Y1kqoydrk2​

#APDW2026 #APDWManila #Gastroenterology

[APASL News @APASLnews]

Join us !! APASL Membership !!
APASL Membership offers such privileges as reduced registration fee for the Annual Meeting and Single Topic Conference (STC) and online free access to Hepatology International, the Official Journal of the APASL !!

https://t.co/lssyZpq1LY

[Journal of Gastroenterology and Hepatology @JGHofficial]

New advances in #IBD are transforming care across the Asia-Pacific 🌏

The latest APAGE Consensus Statements provide region-specific guidance on emerging therapies for Ulcerative Colitis & Crohn’s Disease

🔗 https://t.co/2cRx8IaC4m

[Journal of Gastroenterology and Hepatology @JGHofficial]

Check out the May issue of the Journal of #Gastroenterology and #Hepatology 📗 #TealJournal

✳️ Population CRC Screening in Asia: Review
✳️ Systemic Therapy for Advanced Pancreatic CA and HCC
✳️ Targeting Gut Microbiota for Acute Pancreatitis

And more 📷 https://t.co/jeHZ3kTOyl

[APDW 2026 Manila @apdw2026manila]

Abstract submission is closing soon ⏳​
​
Join APDW 2026 Manila and showcase your research in digestive health. Selected abstracts will be featured in JGH.​

📅 24–28 Nov 2026 | 📍 PICC, Manila​
🗓 Deadline: 15 June 2026​
​
🔗 https://t.co/Y1kqoydZ9A​

#APDW2026 #GICommunity

[APDW 2026 Manila @apdw2026manila]

🇻🇳 We’re live at the ASEAN Laparoscopic HPB Surgery Conference / Vietnam HPB Surgery Congress 2026 in Da Nang!

Visit the APDW 2026 Manila booth at the Exhibitor Area and pick up your complimentary button pins ✨📍

See you there! #APDW2026Manila

[APDW 2026 Manila @apdw2026manila]

Advancing digestive wellness in Asia Pacific 🌏Explore insights from leading experts on innovations, challenges & the future of gastroenterology.

📅 24–28 Nov 2026
📍 PICC, Manila

Learn more: https://t.co/Y1kqoydZ9A
#APDW2026 #APDWManila #DigestiveHealth

[APDW 2026 Manila @apdw2026manila]

Attending PCP Congress at SMX Manila (May 4–6, 2026)? Stop by the APDW 2026 booth at the Exhibitor Area & grab your free button pins 📍✨See you at APDW 2026 Manila later this year! #APDW2026Manila #YouGutToBeHer

[APASL News @APASLnews]

APASL has SNS platforms to post our latest activities !!

[APASL Official SNS]
Facebook https://t.co/mZkVus8KIi
X (Twitter) https://t.co/hRENP0k9X7
Instagram https://t.co/I4aaVen2tK
LinkedIn https://t.co/Pw5XLoGck4

[Louis Lau @LouisHSLau]

Finally out in @AGA_CGH! 📝

Our HK population-based observational study demonstrated a lower 2-year risk of complicated #UGIB in apixaban users compared to edoxaban (NNH 244) and rivaroxaban (NNH 427). 🚨

https://t.co/clH7WmRbfK